ProShare Advisors’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-561	Closed	-$37K	–	2228
2022 Q1	$37K	Sell	561 -147	-21%	-$9.7K	﹤0.01%	2135
2021 Q4	$86K	Buy	+708	New	+$86K	﹤0.01%	2222